Fundraising FoxBiotech Startups
11,077 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
MyFloraDNA is a biotechnology company providing genomic testing products, services, and education for the cannabis industry. It serves growers worldwide, aiming to help improve crop yields, quality, and sustainability through access to genomic sciences.
0 investors
Myocardial Solutions develops MyoStrain, a cardiac MRI technology that measures regional heart function for clinical and research use. The company serves healthcare institutions and medical professionals in the cardiology and imaging sectors.
0 investors
Myosana Therapeutics develops non-viral, muscle-targeted gene therapies aimed at slowing skeletal muscle degeneration and heart failure in Duchenne muscular dystrophy (DMD) and other neuromuscular and cardiac diseases. The company works in the biotech and gene therapy field.
0 investors
0 investors
Myris Therapeutics applies polymer chemistry to develop next-generation medicines, with a flagship platform of ultra-high DAR antibody drug conjugates (ADCs). Its technology uses ATRP "growing from" methods to build polymer bottlebrushes that carry payloads, aimed at targeted cancer therapies across oncogenic pathways.
0 investors
Myrtelle develops gene therapies for neurological diseases, particularly white matter disorders of the central nervous system. The company is conducting clinical trials for Canavan disease using novel AAV vector technology to target oligodendrocytes.
0 investors
0 investors
Namida is an early cancer detection company. The referenced page is a biography of an advisory board member rather than a description of the company's products.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Nanoscope Therapeutics develops therapies for patients with complex retinal diseases that have high unmet need, including inherited retinal degenerations. The company focuses on treatments aimed at restoring vision in people affected by retinal blindness.
0 investors
0 investors
0 investors